2-69387029-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001244710.2(GFPT1):​c.7+36T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.594 in 1,484,594 control chromosomes in the GnomAD database, including 266,085 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.66 ( 34472 hom., cov: 34)
Exomes 𝑓: 0.59 ( 231613 hom. )

Consequence

GFPT1
NM_001244710.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.280

Publications

12 publications found
Variant links:
Genes affected
GFPT1 (HGNC:4241): (glutamine--fructose-6-phosphate transaminase 1) This gene encodes the first and rate-limiting enzyme of the hexosamine pathway and controls the flux of glucose into the hexosamine pathway. The product of this gene catalyzes the formation of glucosamine 6-phosphate. [provided by RefSeq, Sep 2008]
GFPT1 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 12
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Illumina
  • congenital myasthenic syndromes with glycosylation defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 2-69387029-A-G is Benign according to our data. Variant chr2-69387029-A-G is described in ClinVar as Benign. ClinVar VariationId is 258544.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.862 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GFPT1NM_001244710.2 linkc.7+36T>C intron_variant Intron 1 of 19 ENST00000357308.9 NP_001231639.1
GFPT1NM_002056.4 linkc.7+36T>C intron_variant Intron 1 of 18 NP_002047.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GFPT1ENST00000357308.9 linkc.7+36T>C intron_variant Intron 1 of 19 5 NM_001244710.2 ENSP00000349860.4

Frequencies

GnomAD3 genomes
AF:
0.659
AC:
100169
AN:
151978
Hom.:
34431
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.869
Gnomad AMI
AF:
0.665
Gnomad AMR
AF:
0.571
Gnomad ASJ
AF:
0.636
Gnomad EAS
AF:
0.468
Gnomad SAS
AF:
0.622
Gnomad FIN
AF:
0.577
Gnomad MID
AF:
0.631
Gnomad NFE
AF:
0.583
Gnomad OTH
AF:
0.628
GnomAD2 exomes
AF:
0.574
AC:
74642
AN:
129932
AF XY:
0.577
show subpopulations
Gnomad AFR exome
AF:
0.858
Gnomad AMR exome
AF:
0.501
Gnomad ASJ exome
AF:
0.666
Gnomad EAS exome
AF:
0.455
Gnomad FIN exome
AF:
0.580
Gnomad NFE exome
AF:
0.575
Gnomad OTH exome
AF:
0.582
GnomAD4 exome
AF:
0.587
AC:
781747
AN:
1332502
Hom.:
231613
Cov.:
24
AF XY:
0.587
AC XY:
387819
AN XY:
660692
show subpopulations
African (AFR)
AF:
0.876
AC:
25921
AN:
29588
American (AMR)
AF:
0.510
AC:
18323
AN:
35902
Ashkenazi Jewish (ASJ)
AF:
0.664
AC:
16347
AN:
24626
East Asian (EAS)
AF:
0.454
AC:
15919
AN:
35080
South Asian (SAS)
AF:
0.609
AC:
47580
AN:
78164
European-Finnish (FIN)
AF:
0.573
AC:
20127
AN:
35118
Middle Eastern (MID)
AF:
0.589
AC:
3272
AN:
5558
European-Non Finnish (NFE)
AF:
0.582
AC:
600662
AN:
1032414
Other (OTH)
AF:
0.599
AC:
33596
AN:
56052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
13635
27270
40904
54539
68174
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16570
33140
49710
66280
82850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.659
AC:
100262
AN:
152092
Hom.:
34472
Cov.:
34
AF XY:
0.655
AC XY:
48699
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.869
AC:
36097
AN:
41538
American (AMR)
AF:
0.570
AC:
8722
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.636
AC:
2207
AN:
3470
East Asian (EAS)
AF:
0.469
AC:
2415
AN:
5150
South Asian (SAS)
AF:
0.620
AC:
2996
AN:
4832
European-Finnish (FIN)
AF:
0.577
AC:
6092
AN:
10558
Middle Eastern (MID)
AF:
0.623
AC:
182
AN:
292
European-Non Finnish (NFE)
AF:
0.583
AC:
39608
AN:
67940
Other (OTH)
AF:
0.633
AC:
1339
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1682
3365
5047
6730
8412
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
782
1564
2346
3128
3910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.563
Hom.:
3294
Bravo
AF:
0.666
Asia WGS
AF:
0.593
AC:
2061
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital myasthenic syndrome 12 Benign:2
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
14
DANN
Benign
0.73
PhyloP100
0.28
PromoterAI
-0.0098
Neutral
RBP_binding_hub_radar
1.0
RBP_regulation_power_radar
2.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6720415; hg19: chr2-69614161; COSMIC: COSV61951263; API